Authors


Ferhina Ali, MD, MPH

Latest:

ARVO 2025: Aflibercept 8mg in treatment-naive AMD

At ARVO 2025, in Salt Lake City, Utah, Ferhina Ali, MD, MPH, talked about her presentation on the early real-world use of aflibercept 8 mg in treatment-naive patients with neovascular age-related macular degeneration


T.Y. Alvin Liu, MD

Latest:

Clearing hurdles to large scale telemedicine adoption

During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye


Brett A. Johnson, PhD

Latest:

Artificial intelligence enhances detection of neuro-ophthalmic disorders

Deep learning discerns IIH, NAION, and normal eyes using single fundus image.


R.V. Paul Chan, MD

Latest:

Partners collaborate on integration of AI-supported ROP telemedicine globally

Siloam Vision and Orbis team up to develop infrastructure to save the vision of premature infants.


Jibran Sharieff, MD

Latest:

Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)

In this final episode, DMEI’s residents share their future plans for expanding the device capabilities and offer practical advice to other up-and-coming creators in eye care technology.


Mark Milner
Mark S. Milner, MD

Latest:

The benefits of cryopreserved amniotic membrane during COVID-19

CAM’s regenerative healing means long-term relief and fewer visits to clinic.


Anat Loewenstein, MD

Latest:

Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging

Advanced monitoring strategies are overcoming significant obstacles in retinal care, as highlighted at the 2025 International SPECTRALIS Symposium — And Beyond (ISS).


Larry Hanover

Latest:

The untapped potential of cell and gene therapy as treatment option

Investigators continue to break new ground, giving hope to patients, physicians.


Lucy Shen, MD

Latest:

EnVision Summit 2025: Complications in glaucoma surgery

At the EnVision Summit 2025 in San Juan, Puerto Rico, Tania Tai, Lucy Shen, and Shivani Kamat all gave insight into complications they have seen while performing glaucoma surgery.


Amy Zhang, MD

Latest:

EnVision Summit 2025: Ergonomics in the operating room

At the Envision Summit 2025 in San Juan, Puerto Rico, Amy Zhang, MD, discussed the importance of ergonomics in the operating room.


Caesar K. Luo, MD, FACS, FASRS

Latest:

Durable therapies for diabetic macular edema amid COVID-19 pandemic

Patients’ reluctance to visit a clinic during the COVID-19 pandemic is pushing retina specialists to optimize therapy.


Hattie Hayes

Latest:

Ruth Hogg, PhD, on what retinal imaging can tell clinicians about the brain and body

With detailed imaging and cognitive data, the Northern Ireland Cohort for the Longitudinal Study of Aging highlights the potential of integrating eye scans into broader health research.


Júlia Jiquilin Carvalho, MD

Latest:

The evolving role of vitreosurgical simulators in surgical training

Need to eliminate errors results in optimization of training of novice surgeons.


Jorge L. Alió, MD, PhD, FEBO

Latest:

Cosmetic surgery of the cornea: A new type of surgery

Keratopigmentation technique offers therapeutic and cosmetic applications.


Tsz Wing Leung, PhD

Latest:

ARVO 2025: 8 year retrospective of DIMS spectacle lens in children

At ARVO 2025, in Salt Lake City, Utah, Carly Lam, PhD, MSc, and Tsz Wing Leung, PhD talked about the evaluation of the visual performance of 2 modified DIMS spectacle lens designs.


Mildred M.G. Olivier, MD

Latest:

The impact of preservatives on the ocular surface in patients with ocular hypertension or glaucoma

Weighing the benefits and trade-offs of preserved versus preservative-free glaucoma treatments is key to optimizing long-term patient care.


John Tan

Latest:

ARVO 2025: Walk through a novel triaging framework for emergent retinal pathologies

Researchers stratified a dataset of more than 100 patients in an emergency department to see which patients may be indicated for retinal artery occlusions.


Adam Wenick, MD, PhD

Latest:

EyeCon 2024: Myopia interventions across the lifespan

Adam S. Wenick, MD, PhD, discussed myopia interventions across the lifespan at EyeCon 2024, covering treatments, complications, and prevention strategies.



T. Y. Alvin Liu, MD

Latest:

Ophthalmology sees AI-powered impact on cataract and diabetic eye disease

Shameema Sikder, MD; and T. Y. Alvin Liu, MD, highlight the technology’s role in bridging challenges and successes for clinical practice.


Refractive Surgery Council

Latest:

Laser vision correction procedures soar in wake of COVID-19

According to the Refractive Surgery Council, patients continue to have a high level of interest in laser vision correction procedures.


Kelly Donovan, MD

Latest:

Envision Summit 2025: Understanding hyperglycemia in diabetic retinopathy

At the Envision Summit 2025 in San Juan, Puerto Rico, Kelly Donovan, MD, talked about her graduate research on the earliest phase of diabetic retinopathy, and trying to understand how hyperglycemia translates into disease.


Mackenzie Andrews

Latest:

Blog: A call to stop discarding eye medications after a single use or before expiration date

In a blog, Mackenzie Andrews, the CCO and a co-founder of Nanodropper, discusses the need to update policies on single-use and early disposal of eyedrops.


Daniel S. Choi, MD

Latest:

Recent changes to cornea: Preferred Practice Patterns

A Q&A with PPP Committee Cornea/External Disease Panel member Daniel S. Choi, MD.


Evangelia Gkaragkani, MD

Latest:

Preserving patients’ vision by monitoring glaucoma progression rate

Three approaches to examination provide a comprehensive overview



Audrey Talley Rostov, MD

Latest:

Keratoconus management: Lessons learned from an unusual time

Timely access to effective diagnosis and cross-linking is key to positive outcomes


Kevin Yang Wu, MD, DMD

Latest:

New therapeutic targets, drug development for RP

Simply slowing disease progression is no longer enough.


Matthew Starr, MD

Latest:

Q&A: Matthew Starr, MD, shares insights into RHONE-X trial

Matthew Starr, MD, highlights the RHONE-X trial's findings on faricimab, showcasing improved vision and reduced treatment burden for diabetic macular edema patients.


Noemi Guemes-Villahoz, MD, PhD

Latest:

ARVO 2025: 12-month results in myopic children using combination treatment of atropine and DIMS spectacle lenses

At ARVO 2025, in Salt Lake City, Utah, Noemi Guemes-Villahoz, MD, PhD, talked about 12-month results of vision-related quality of life in myopic children using combination treatment with atropine and DIMS (Defocus Incorporated Multiple Segments) spectacle lenses.

© 2025 MJH Life Sciences

All rights reserved.